 | |
| TSX: ZENA | |
| Industry | Cannabis |
| Predecessor | International Herbs Medical Marijuana Ltd |
| Founded | 2014 |
| Founders | Monty Sikka, Mark Catroppa |
| Fate | Acquired by HEXO Corp. |
Area served | Global |
| Products | Zenabis (medical marijuana) Namaste (recreational marijuana) Blazery (recreational marijuana) Re-Up (recreational marijuana) |
| Website | zenabis |
Zenabis Global Inc. was a Canadian medical and recreational marijuana producer.
Zenabis was originally known by the name International Herbs Medical Marijuana Ltd. and was co-founded by Monty Sikka and Mark Catroppa. [1] It purchased its first facility in 2014 in New Brunswick and received a cultivation license from Health Canada in 2017. [2] Zenabis received its sales license for dried marijuana from Health Canada in 2018, [1] and received its license to sell cannabis oil in March 2019. [3] [4] In January 2019, Zenabis’s parent company Sun Pharm completed a reverse take-over of Bevo Agro Inc., leading to the two firms operating under the banner of Zenabis Global Inc. [5] The company was traded on the TSX under the ticker symbol ZENA.
Like all medical marijuana companies in Canada, Zenabis has struggled on the stock market. [6] The company was acquired by HEXO Corp in 2021 in an all-stock deal. [7]
MedMen Enterprises was a United States-based cannabis company. At its peak, it had operations in California, Nevada, Arizona, Florida, Illinois, New York, and Massachusetts. MedMen owns and operates 29 retail stores and 6 cultivation facilities and is currently licensed to expand its footprint to 65 retail locations. Its stock trades on the Canadian Securities Exchange under the ticker symbol MMEN. MedMen is also traded over-the-counter in the United States under the ticker symbol MMNFF. MedMen is based in Culver City, California and has more than 1,000 employees.
Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario.
Cboe Canada is a stock exchange based in Toronto. Part of the Cboe Global Markets network, the exchange has over 260 listings for public companies, exchange-traded funds (ETFs), Canadian Depositary Receipts (CDRs), Special Purpose Acquisition Companies (SPACs), and closed-end funds. Cboe Canada handles 15% of the volume traded across Canadian marketplaces, including 20% of Canadian ETF transactions.
CanniMed Therapeutics Inc. is a Canadian public licensed producer of medical cannabis. It is primarily focused on cannabis oil. The company's predecessor, Prairie Plant Systems, was established in 1988 and is located in Saskatoon, Saskatchewan. In 2013 CanniMed became the first cannabis producer to be licensed under Health Canada regulations that were issued that year. It went public in 2016, and in March 2018 almost all of its stock was acquired by a rival producer, Aurora Cannabis, following a hostile takeover to which company management finally consented.
The possession, use, and distribution of cannabis without a license in the State of Israel are violations under the Dangerous Drugs Ordinance. A decade ago, despite these regulations, enforcement was relatively lax, partially influenced by a political movement advocating tolerance. Over the years, the enforcement approach has progressively become more lenient. As of 2021, cannabis use has been fully decriminalized, with it being treated as an administrative infraction primarily when used in highly visible public places. There is a possibility that cannabis may be legalized for recreational use by adults aged 21 and older in the future, with regulations akin to those for alcohol. Public and cross-party political support for the complete decriminalization of cannabis increased in the 2010s with increasing usage for both medical and recreational purposes, and the establishment of a political party primarily devoted to this cause; on July 19, 2018, the Knesset approved a bill for decriminalization, although the supporters of recreational cannabis use insisted that this did not represent complete decriminalization. The law came into effect on April 1, 2019. On June 25, 2020, further legislation designed to decriminalize possession of up to 50 grams of cannabis began its passage through the Knesset.
Tokyo Smoke is a Canadian lifestyle brand owned by OEG Inc. that focuses on the legal recreational cannabis industry. The company was co-founded by father and son Lorne and Alan Gertner in 2015.
The Cannabis Act is a law which legalized recreational cannabis use in Canada in combination with its companion legislation Bill C-46, An Act to Amend the Criminal Code. The law is a milestone in the legal history of cannabis in Canada, alongside the 1923 prohibition.
Cannabis in New Brunswick became legal for recreational use when the Cannabis Act went into force across the country on October 17, 2018.
On October 17, 2018, cannabis was legalized in Canada for recreational and medical purposes. It was already legal for medicinal purposes, under conditions outlined in the Marihuana for Medical Purposes Regulations issued by Health Canada, and for seed, grain, and fibre production under licence by Health Canada.
Cannabis in Prince Edward Island became legal when the national Cannabis Act went into force on October 17, 2018.
Cannabis in Yukon became legal when the national Cannabis Act went into force on October 17, 2018.
Aphria Inc., headquartered in Leamington, Ontario, was an international producer and distributor of medicinal and recreational cannabis. The company operated through retail and wholesale channels in Canada and internationally.
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB.
VIVO Cannabis Inc(formerly ABcann Global) is a Canadian licensed cannabis producer, headquartered in Napanee, Ontario. Prior to being acquired by MediPharm Labs Corp., VIVO traded on the Toronto Stock Exchange as VIVO.
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.
Global X Investments Canada Inc. is a financial services company that offers exchange-traded funds. On May 1, 2024, the company changed its name from Horizons ETFs to Global X Investments Canada Inc. In April 2017, Global X began offering the first cannabis industry focused exchange-traded fund (ETF), Global X Marijuana Life Sciences Index ETF. The company is also the fourth-largest ETF provider in Canada, with more than CAD$30 billion in assets as of April 2023.
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company's stock trades on the Canadian Securities Exchange under the ticker symbol CL, and in over-the-counter markets in the United States with the ticker symbol CRLBF.
Curaleaf Holdings, Inc. is an American cannabis company publicly traded on the Canadian stock exchange. The company is headquartered in New York City. Founded in 2010, it produces and distributes cannabis products in North America, operating dispensaries in 19 states. The company is headquartered in New York City, and is the world's largest cannabis company by revenue.
The Green Rush (2012–present) is an ongoing global economic event that began on December 6, 2012, when cannabis was legalized in the US state of Washington; Colorado's legalization took effect four days later. While still illegal federally in the United States, the actions of these two state governments signaled the opening of a market projected to be worth US$48+ billion globally by 2027. As of 2019 the cannabis industry had created over 250,000 jobs. However, cannabis companies have been a mixed investment success, with many experiencing plunging stock prices, massive layoffs, and failure to meet investor expectations.
